$2.85 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 114 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 32.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $130,401,000 | +4.5% | 6,988,248 | -18.9% | 4.58% | +5.9% |
| HZNP | HORIZON PHARMA PLC | $109,460,000 | +16.6% | 6,609,894 | 0.0% | 3.84% | +18.2% | |
| FIXX | HOMOLOGY MEDICINES INC | $106,632,000 | +9.1% | 5,227,035 | 0.0% | 3.74% | +10.6% | |
| HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $94,914,000 | +4.2% | 99,100,000 | 0.0% | 3.33% | +5.6% | ||
| MRTX | Buy | MIRATI THERAPEUTICS INC | $64,108,000 | +960.0% | 1,300,365 | +560.1% | 2.25% | +971.9% |
| MYL | Sell | MYLAN N V | $62,960,000 | -40.0% | 1,742,111 | -31.6% | 2.21% | -39.2% |
| MYOK | Buy | MYOKARDIA INC | $57,544,000 | +10.3% | 1,159,000 | +8.5% | 2.02% | +11.8% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $56,664,000 | +3493.2% | 2,573,305 | +709.2% | 1.99% | +3518.2% |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $55,941,000 | -16.4% | 2,900,000 | 0.0% | 1.96% | -15.3% | |
| KEMPHARM INCnote 5.500% 2/0 | $55,438,000 | -3.2% | 75,000,000 | 0.0% | 1.95% | -1.9% | ||
| ACRS | ACLARIS THERAPEUTICS INC | $54,832,000 | +14.0% | 2,745,705 | 0.0% | 1.93% | +15.5% | |
| XLRN | Buy | ACCELERON PHARMA INC | $54,672,000 | +127.4% | 1,126,800 | +83.2% | 1.92% | +130.5% |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $54,639,000 | – | 1,446,633 | +100.0% | 1.92% | – |
| XERS | New | XERIS PHARMACEUTICALS INC | $47,425,000 | – | 2,498,666 | +100.0% | 1.66% | – |
| ANTM | ANTHEM INC | $45,464,000 | +8.3% | 191,000 | 0.0% | 1.60% | +9.8% | |
| AET | Buy | AETNA INC NEW | $42,022,000 | +50.7% | 229,000 | +38.8% | 1.48% | +52.8% |
| WRIGHT MED GROUP N Vnote 2.250%11/1 | $41,943,000 | +17.3% | 31,500,000 | 0.0% | 1.47% | +18.9% | ||
| EDIT | EDITAS MEDICINE INC | $41,521,000 | +8.1% | 1,158,841 | 0.0% | 1.46% | +9.5% | |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $40,061,000 | -3.7% | 1,048,430 | -24.3% | 1.41% | -2.4% |
| ANAB | Sell | ANAPTYSBIO INC | $39,995,000 | -51.6% | 562,989 | -29.1% | 1.40% | -50.9% |
| CNC | Sell | CENTENE CORP DEL | $39,986,000 | -36.4% | 324,536 | -44.8% | 1.40% | -35.5% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $39,125,000 | – | 296,000 | +100.0% | 1.37% | – |
| ENDOLOGIX INCnote 3.250%11/0 | $38,243,000 | +9.6% | 40,500,000 | 0.0% | 1.34% | +11.1% | ||
| XENT | Buy | INTERSECT ENT INC | $38,199,000 | +16.8% | 1,020,000 | +22.5% | 1.34% | +18.3% |
| ARGX | Buy | ARGENX SEsponsored adr | $37,041,000 | +43.9% | 447,029 | +39.7% | 1.30% | +45.9% |
| CVS | CVS HEALTH CORPcall | $36,474,000 | +3.4% | 566,800 | 0.0% | 1.28% | +4.8% | |
| CVS | CVS HEALTH CORP | $35,393,000 | +3.4% | 550,000 | 0.0% | 1.24% | +4.9% | |
| Sell | TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $35,398,000 | -8.2% | 43,000,000 | -10.4% | 1.24% | -7.0% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $34,744,000 | -1.1% | 6,063,496 | -17.7% | 1.22% | +0.2% |
| SEM | SELECT MED HLDGS CORP | $33,723,000 | +5.2% | 1,858,000 | 0.0% | 1.18% | +6.7% | |
| AERI | AERIE PHARMACEUTICALS INC | $32,698,000 | +24.5% | 484,055 | 0.0% | 1.15% | +26.2% | |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $32,513,000 | +28.0% | 233,000 | +3.3% | 1.14% | +29.8% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $32,094,000 | +1.7% | 482,467 | 0.0% | 1.13% | +3.1% | |
| ECYT | Sell | ENDOCYTE INC | $32,075,000 | +34.3% | 2,324,299 | -11.5% | 1.13% | +36.2% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $31,868,000 | +36.7% | 531,000 | +49.2% | 1.12% | +38.5% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $31,598,000 | +10.5% | 36,000,000 | 0.0% | 1.11% | +12.0% | ||
| GKOS | Sell | GLAUKOS CORP | $30,652,000 | -39.5% | 754,222 | -54.1% | 1.08% | -38.7% |
| ACHC | ACADIA HEALTHCARE COMPANY IN | $30,315,000 | +4.4% | 741,016 | 0.0% | 1.06% | +5.9% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $30,150,000 | -13.2% | 474,950 | +25.3% | 1.06% | -12.0% |
| NEVRO CORPnote 1.750% 6/0 | $29,913,000 | -4.3% | 27,600,000 | 0.0% | 1.05% | -3.0% | ||
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $29,481,000 | -1.5% | 350,000 | -4.4% | 1.04% | -0.2% |
| UHS | UNIVERSAL HLTH SVCS INCcl b | $29,197,000 | -5.9% | 262,000 | 0.0% | 1.02% | -4.7% | |
| IMMU | Buy | IMMUNOMEDICS INC | $26,624,000 | +95.9% | 1,124,800 | +20.9% | 0.94% | +98.5% |
| K2M GROUP HLDGS INCnote 4.125% 8/1 | $26,036,000 | +11.1% | 20,000,000 | 0.0% | 0.91% | +12.6% | ||
| MLNT | Buy | MELINTA THERAPEUTICS INC | $25,373,000 | +9.6% | 3,995,806 | +27.7% | 0.89% | +11.1% |
| DFBHU | DFB HEALTHCARE ACQUISTION COunit 01/30/2023 | $25,375,000 | +1.0% | 2,500,000 | 0.0% | 0.89% | +2.4% | |
| LCI | Sell | LANNET INC | $24,498,000 | -44.3% | 1,801,353 | -34.3% | 0.86% | -43.6% |
| EHTH | Buy | EHEALTH INC | $24,419,000 | +65.5% | 1,104,952 | +7.2% | 0.86% | +67.9% |
| EPZM | Buy | EPIZYME INC | $22,208,000 | +30.2% | 1,639,000 | +70.6% | 0.78% | +32.0% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $21,995,000 | +89.9% | 703,600 | +20.9% | 0.77% | +92.5% |
| DEPOMED INCnote 2.500% 9/0 | $21,952,000 | -0.2% | 27,019,000 | 0.0% | 0.77% | +1.2% | ||
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $21,316,000 | +166.5% | 609,554 | +56.3% | 0.75% | +170.4% |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $21,287,000 | – | 1,226,890 | +100.0% | 0.75% | – |
| BKD | New | BROOKDALE SR LIVING INC | $20,959,000 | – | 2,305,773 | +100.0% | 0.74% | – |
| NTRA | Sell | NATERA INC | $20,341,000 | -31.0% | 1,080,829 | -66.0% | 0.71% | -30.1% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $19,342,000 | -8.5% | 21,000,000 | 0.0% | 0.68% | -7.2% | ||
| MOR | New | MORPHOSYS AGsponsored ads | $18,204,000 | – | 600,000 | +100.0% | 0.64% | – |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $18,097,000 | -19.9% | 673,000 | -5.2% | 0.64% | -18.8% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $18,025,000 | +14.4% | 1,343,181 | +10.7% | 0.63% | +15.9% |
| BLUE | Buy | BLUEBIRD BIO INC | $17,735,000 | +153.3% | 113,000 | +175.6% | 0.62% | +156.4% |
| AACH | AAC HLDGS INC | $17,372,000 | -18.4% | 1,853,998 | 0.0% | 0.61% | -17.2% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $17,361,000 | -37.0% | 398,194 | -42.9% | 0.61% | -36.1% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $16,899,000 | -6.0% | 1,311,000 | -9.2% | 0.59% | -4.8% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $16,687,000 | -22.1% | 729,948 | -3.1% | 0.59% | -21.1% |
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $16,687,000 | -39.6% | 2,722,241 | -28.1% | 0.59% | -38.8% |
| MOH | MOLINA HEALTHCARE INC | $16,454,000 | +20.6% | 168,000 | 0.0% | 0.58% | +22.2% | |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $15,729,000 | -29.7% | 398,000 | -54.2% | 0.55% | -28.9% |
| DXCM | Sell | DEXCOM INC | $15,688,000 | -67.4% | 165,175 | -74.5% | 0.55% | -67.0% |
| GLPG | Buy | GALAPAGOS NVspon adr | $15,210,000 | +17.3% | 165,000 | +26.9% | 0.53% | +18.9% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $14,380,000 | -17.3% | 146,000 | 0.0% | 0.50% | -16.1% | |
| NVTA | INVITAE CORP | $13,978,000 | +56.7% | 1,901,788 | 0.0% | 0.49% | +58.9% | |
| ZBH | ZIMMER BIOMET HLDGS INC | $13,484,000 | +2.2% | 121,000 | 0.0% | 0.47% | +3.7% | |
| SYBX | SYNLOGIC INC | $13,419,000 | +4.8% | 1,365,143 | 0.0% | 0.47% | +6.1% | |
| SYRS | SYROS PHARMACEUTICALS INC | $12,956,000 | -21.3% | 1,268,945 | 0.0% | 0.46% | -20.3% | |
| ARDX | Buy | ARDELYX INC | $12,920,000 | -1.7% | 3,491,922 | +34.2% | 0.45% | -0.2% |
| SIEN | Buy | SIENTRA INC | $12,664,000 | +1091.3% | 649,100 | +490.1% | 0.44% | +1102.7% |
| GTHX | Sell | G1 THERAPEUTICS INC | $12,473,000 | -9.7% | 287,000 | -23.1% | 0.44% | -8.6% |
| AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $10,707,000 | -18.8% | 16,600,000 | 0.0% | 0.38% | -17.7% | ||
| New | TELIGENT INC NEWnote 4.750% 5/0 | $10,312,000 | – | 9,567,000 | +100.0% | 0.36% | – | |
| FTSV | New | FORTY SEVEN INC | $9,600,000 | – | 600,000 | +100.0% | 0.34% | – |
| PRTA | New | PROTHENA CORP PLC | $9,160,000 | – | 628,262 | +100.0% | 0.32% | – |
| IVTY | INVUITY INC | $9,114,000 | +1.3% | 2,336,889 | 0.0% | 0.32% | +2.6% | |
| WMGI | Sell | WRIGHT MED GROUP N V | $9,074,000 | -27.9% | 349,539 | -44.9% | 0.32% | -26.8% |
| RGNX | Sell | REGENXBIO INC | $8,969,000 | +17.2% | 125,000 | -51.2% | 0.32% | +18.9% |
| TBIO | New | TRANSLATE BIO INC | $8,223,000 | – | 650,000 | +100.0% | 0.29% | – |
| Sell | NUVASIVE INCnote 2.250% 3/1 | $7,591,000 | -31.0% | 7,000,000 | -30.0% | 0.27% | -29.9% | |
| ECOR | New | ELECTROCORE INC | $7,017,000 | – | 425,000 | +100.0% | 0.25% | – |
| ALPN | ALPINE IMMUNE SCIENCES INC | $6,912,000 | -5.4% | 913,100 | 0.0% | 0.24% | -4.0% | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $6,839,000 | -36.4% | 178,806 | -33.3% | 0.24% | -35.7% |
| BIOS | Sell | BIOSCRIP INC | $6,842,000 | -11.0% | 2,335,000 | -25.3% | 0.24% | -9.8% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $6,698,000 | – | 250,000 | +100.0% | 0.24% | – |
| EIDX | New | EIDOS THERAPEUTICS INC | $6,586,000 | – | 323,807 | +100.0% | 0.23% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $6,391,000 | – | 179,381 | +100.0% | 0.22% | – |
| PFNX | Sell | PFENEX INC | $6,112,000 | -38.6% | 1,129,684 | -31.9% | 0.22% | -37.7% |
| ALIM | ALIMERA SCIENCES INC | $5,922,000 | -5.0% | 6,052,935 | 0.0% | 0.21% | -3.7% | |
| AVRO | New | AVROBIO INC | $5,712,000 | – | 200,000 | +100.0% | 0.20% | – |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $5,496,000 | -26.7% | 280,000 | -30.0% | 0.19% | -25.8% |
| SRRA | SIERRA ONCOLOGY INC | $5,224,000 | +43.0% | 1,764,889 | 0.0% | 0.18% | +44.1% | |
| ALBO | ALBIREO PHARMA INC | $4,260,000 | +9.0% | 120,000 | 0.0% | 0.15% | +11.1% | |
| STDY | Sell | STEADYMED LTD | $4,132,000 | -10.4% | 918,120 | -35.3% | 0.14% | -9.4% |
| RARX | RA PHARMACEUTICALS INC | $3,808,000 | +87.4% | 382,700 | 0.0% | 0.13% | +91.4% | |
| Sell | IGI LABORATORIES INCnote 3.750%12/1 | $3,476,000 | -67.7% | 3,733,000 | -67.8% | 0.12% | -67.2% | |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $3,377,000 | -2.3% | 674,002 | 0.0% | 0.12% | -0.8% | |
| STIM | New | NEURONETICS INC | $3,326,000 | – | 125,000 | +100.0% | 0.12% | – |
| PRTO | PROTEON THERAPEUTICS INC | $3,001,000 | -2.0% | 1,224,899 | 0.0% | 0.10% | -0.9% | |
| MNKD | Sell | MANNKIND CORP | $2,771,000 | -18.0% | 1,458,537 | -1.6% | 0.10% | -17.1% |
| NVTRQ | New | NUVECTRA CORP | $2,689,000 | – | 131,000 | +100.0% | 0.09% | – |
| TLGT | Buy | TELIGENT INC NEW | $2,453,000 | +52.5% | 708,873 | +48.0% | 0.09% | +53.6% |
| VYGR | VOYAGER THERAPEUTICS INC | $2,299,000 | +4.0% | 117,647 | 0.0% | 0.08% | +5.2% | |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $2,152,000 | +145.4% | 80,783 | +38.7% | 0.08% | +153.3% |
| EYEN | EYENOVIA INC | $1,890,000 | -31.1% | 300,000 | 0.0% | 0.07% | -30.5% | |
| XNCR | Sell | XENCOR INC | $1,790,000 | -93.2% | 48,366 | -94.5% | 0.06% | -93.1% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $1,458,000 | -79.7% | 233,332 | -73.0% | 0.05% | -79.5% |
| ARLZ | ARALEZ PHARMACEUTICALS INC | $576,000 | -76.7% | 1,644,583 | 0.0% | 0.02% | -76.5% | |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -1,020,000 | -100.0% | -0.05% | – |
| OBLN | Exit | OBALON THERAPEUTICS INC | $0 | – | -446,284 | -100.0% | -0.05% | – |
| EGLTQ | Exit | EGALET CORP | $0 | – | -3,239,237 | -100.0% | -0.07% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -422,000 | -100.0% | -0.08% | – |
| TSRO | Exit | TESARO INC | $0 | – | -42,893 | -100.0% | -0.08% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -88,500 | -100.0% | -0.09% | – |
| TCMD | Exit | TACTILE SYS TECHNOLOGY INC | $0 | – | -91,020 | -100.0% | -0.10% | – |
| ARMO | Exit | ARMO BIOSCIENCES INC | $0 | – | -188,525 | -100.0% | -0.24% | – |
| Exit | ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0 | $0 | – | -9,671,000 | -100.0% | -0.34% | – | |
| Exit | EXACT SCIENCES CORPdbcv 1.000% 1/1 | $0 | – | -12,500,000 | -100.0% | -0.38% | – | |
| REPH | Exit | RECRO PHARMA INC | $0 | – | -1,010,000 | -100.0% | -0.38% | – |
| PODD | Exit | INSULET CORP | $0 | – | -171,000 | -100.0% | -0.51% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -426,749 | -100.0% | -0.56% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCcall | $0 | – | -500,000 | -100.0% | -0.57% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INCput | $0 | – | -500,000 | -100.0% | -0.57% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -150,000 | -100.0% | -0.73% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -830,605 | -100.0% | -0.74% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCsponsored adr | $0 | – | -810,000 | -100.0% | -1.10% | – |
| DVA | Exit | DAVITA INC | $0 | – | -486,427 | -100.0% | -1.11% | – |
| Exit | ISIS PHARMACEUTICALS INC DELnote 1.000%11/1 | $0 | – | -45,700,000 | -100.0% | -1.57% | – | |
| AVXS | Exit | AVEXIS INC | $0 | – | -755,798 | -100.0% | -3.24% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.